Background: The mechanism of anti-hepatitis B virus effects of PSP is unclear. Methods: Human peripheral blood mononuclear Cells (PBMCs) obtained from healthy volunteer were co-cultured with PSP. The ratio of CD4+/CD8+ and the expression of CD3+HLA-DR+ and CD19+CD69+ of PBMCs were assessed by flow cytometry at 72 hours, meanwhile, detecting the levels of IFN-g, IL-12 and IgG in supernatant by ELISA. Then HepG2.2.15 cells were divided into four groups (Table 1) . HBVDNA load and the levels of HBsAg and HBeAg in supernatant were detected by fluorescent-quantitative PCR and Abbott-chemiluminescent microparticle immunoassay respectively at 96 h. Results: At 72h, the ratio of CD4+/CD8+ in PBMCs+PSP group was significantly higher than PBMCs group (p < 0.05), and, the expression of CD3+/HLA-DR+ and CD19+/CD69+ in PBMCs+PSP group were higher than PBMCs group, however, have no statistical significance. PSP could increase IFN-g, IL-12 and IgG (Graph 1). PSP couldn't inhibit HBV replication directly; PBMCs activated by PSP reduced HBsAg and HBeAg secretion significantly, however, have no remarkable inhibitory effects of HBVDNA (Table 1) .
Graph 1. Effect of PSP on IFN-g, IL-12 and IgG secretion by PBMCs at 72 h (n = 7). 
